Product
ABP 959
1 clinical trial
1 indication
Indication
Paroxysmal Nocturnal HemoglobinuriaClinical trial
A Randomized, Double-Blind, Active-Controlled Phase 3 Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)Status: Completed, Estimated PCD: 2022-07-12